Integrated EHR Solutions NeoGenomics recent integration with Epic Aura positions it as a strategic partner for healthcare providers seeking seamless oncology testing workflows directly within their EHR systems, creating an opportunity to upsell additional diagnostic services and data solutions.
Innovative Testing Portfolio The launch of new products like RaDaR ST for MRD detection and PanTracer Pro demonstrates NeoGenomics focus on advanced molecular diagnostics, which can be promoted to healthcare institutions aiming to differentiate their precision medicine offerings.
Research and Thought Leadership Participation in high-profile conferences such as AACR and SABCS highlights NeoGenomics commitment to scientific innovation, providing sales teams with entry points to connect with research institutions and academic medical centers interested in cutting-edge cancer diagnostics.
Significant Funding and Growth With $200 million in funding, NeoGenomics has the financial backing to expand its product suite and market reach, creating opportunities for resellers and partners to collaborate on new cancer testing solutions and service expansions.
Market Positioning As a leading provider in oncology diagnostics with a growing portfolio and focus on precision medicine, NeoGenomics presents opportunities for strategic partners to align with a company that is poised for increased market penetration among large health systems and specialty care providers.
$10B
$100M$250M
$10B
$250M$500M
$500M$1B
$1B$10B
$1B$10B
$1B$10B
$500M$1B
$10M$25MNeoGenomics Laboratories uses 8 technology products and services including Oracle Fusion Cloud Financials, ggplot2, Twitter Ads, and more. Explore NeoGenomics Laboratories's tech stack below.
| NeoGenomics Laboratories Email Formats | Percentage |
| First.Last@neogenomics.com | 87% |
| FLast@neogenomics.com | 12% |
| First.Middle@neogenomics.com | 1% |
Hospitals and Health CareFlorida, United States1001-5000 Employees
Our vision: A world where every cancer treatment decision is as personal as the patient. Our mission: We take cancer personally. We partner with physicians to deliver actionable insights that guide personalized treatment decisions and improve outcomes -- through a comprehensive oncology portfolio and an unwavering commitment to excellence powered by a team of dedicated experts.
Company Overview
Funding & FinancialsNeoGenomics Laboratories has raised a total of $200M of funding over 7 rounds. Their latest funding round was raised on May 05, 2021 in the amount of $200M.
NeoGenomics Laboratories's revenue is estimated to be in the range of $500M$1B
Funding & FinancialsNeoGenomics Laboratories has raised a total of $200M of funding over 7 rounds. Their latest funding round was raised on May 05, 2021 in the amount of $200M.
NeoGenomics Laboratories's revenue is estimated to be in the range of $500M$1B
1-888-653-2347 
support@leadiq.com